Literature DB >> 13903363

Extrapyramidal modification of fine movements: a "conditio sine qua non" of the fundamental therapeutic action of neuroleptic drugs.

H J HAASE.   

Abstract

Keywords:  EXTRAPYRAMIDAL TRACTS/pharmacology; HANDWRITING/pharmacology; MOVEMENT/pharmacology; TRANQUILIZING AGENTS/pharmacology

Mesh：

Substances：

Year:  1961        PMID： 13903363

Source DB:  PubMed          Journal:  Rev Can Biol        ISSN： 0035-0915


× No keyword cloud information.
  10 in total

Review 1.  Choosing the right dose of antipsychotics in schizophrenia: lessons from neuroimaging studies.

Authors:  J Tauscher; S Kapur
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

Review 2.  Managing antipsychotic-induced parkinsonism.

Authors:  D C Mamo; R A Sweet; M S Keshavan
Journal:  Drug Saf       Date:  1999-03       Impact factor: 5.606

Review 3.  Dose response and atypical antipsychotics in schizophrenia.

Authors:  Bruce J Kinon; Jonna Ahl; Virginia L Stauffer; Angela L Hill; Peter F Buckley
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

4.  Handwriting movement kinematics for quantifying extrapyramidal side effects in patients treated with atypical antipsychotics.

Authors:  Michael P Caligiuri; Hans-Leo Teulings; Charles E Dean; Alexander B Niculescu; James B Lohr
Journal:  Psychiatry Res       Date:  2010-04-09       Impact factor: 3.222

5.  A quantitative measure of handwriting dysfluency for assessing tardive dyskinesia.

Authors:  Michael P Caligiuri; Hans-Leo Teulings; Charles E Dean; James B Lohr
Journal:  J Clin Psychopharmacol       Date:  2015-04       Impact factor: 3.153

Review 6.  Clozapine plasma level monitoring: current status.

Authors:  T B Cooper
Journal:  Psychiatr Q       Date:  1996

7.  Handwriting movement analyses for monitoring drug-induced motor side effects in schizophrenia patients treated with risperidone.

Authors:  Michael P Caligiuri; Hans-Leo Teulings; Charles E Dean; Alexander B Niculescu; James Lohr
Journal:  Hum Mov Sci       Date:  2009-08-18       Impact factor: 2.161

Review 8.  Pharmacokinetic optimisation of the treatment of psychosis.

Authors:  A E Balant-Gorgia; L P Balant; A Andreoli
Journal:  Clin Pharmacokinet       Date:  1993-09       Impact factor: 6.447

9.  Clozapine for severe ("kraepelinian") schizophrenia: Sustained improvement over 5 years.

Authors:  Ricardo de Oliveira-Souza; Rogério Paysano Marrocos; Jorge Moll
Journal:  Dement Neuropsychol       Date:  2008 Jan-Mar

Review 10.  Increasing antipsychotic dose for non response in schizophrenia.

Authors:  Myrto T Samara; Elisabeth Klupp; Bartosz Helfer; Philipp H Rothe; Johannes Schneider-Thoma; Stefan Leucht
Journal:  Cochrane Database Syst Rev       Date:  2018-05-11
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.